IMAX | ImaxNYSETechnologyCommon stock golden cross and death cross projections, cross tests and history

$50.49
+$0.69 (+1.39%)

Imax (IMAX) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $50.49 vs 50 $52.32 / 200 $43.01
Projection
No cross projected
Test
No active test
Last cross
Golden cross 18 Jun 2024 ยท not projected ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $50.61 vs 50 $41.79 / 200 $26.30
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 18 Nov 2024 ยท projected 30 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $50.49 vs 50 $51.83 / 200 $48.63
Projection
No cross projected
Test
No active test
Last cross
Golden cross 12 Jun 2026 ยท projected 26 bars out

Cross history

32
crosses on record since 2018
17 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 Jun 2026Golden4-hour26 bars outNot tested
4 May 2026Death4-hour3 bars out1 bar cross test
4 Sep 2025Golden4-hour14 bars outโ€”
22 Aug 2025Death4-hour29 bars outโ€”
21 May 2025Golden4-hour27 bars outโ€”

About IMAX

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$49.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorTechnology
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.